CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update.

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy Antibodies, Antineutrophil Cytoplasmic Canada Consensus Cytoplasm Humans
antineutrophil cytoplasm antibody-associated vasculitis eosinophilic granulomatosis with polyangiitis glomerulonephritis granulomatosis with polyangiitis microscopic polyangiitis

Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
04 2021
Historique:
accepted: 05 09 2020
pubmed: 17 9 2020
medline: 1 9 2021
entrez: 16 9 2020
Statut: ppublish

Résumé

In 2015, the Canadian Vasculitis Research Network (CanVasc) created recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) in Canada. The current update aims to revise existing recommendations and create additional recommendations, as needed, based on a review of new available evidence. A needs assessment survey of CanVasc members informed questions for an updated systematic literature review (publications spanning May 2014 to September 2019) using Medline, Embase, and Cochrane. New and revised recommendations were developed and categorized according to the level of evidence and strength of each recommendation. The CanVasc working group used a 2-step modified Delphi procedure to reach > 80% consensus on the inclusion, wording, and grading of each new and revised recommendation. Eleven new and 16 revised recommendations were created and 12 original (2015) recommendations were retained. New and revised recommendations are discussed in detail within this document. Five original recommendations were removed, of which 4 were incorporated into the explanatory text. The supplementary material for practical use was revised to reflect the updated recommendations. The 2020 updated recommendations provide rheumatologists, nephrologists, and other specialists caring for patients with AAV in Canada with new management guidance, based on current evidence and consensus from Canadian experts.

Identifiants

DOI: 10.3899/jrheum.200721 PMID: 32934123
pubmed: 32934123
pii: jrheum.200721
doi: 10.3899/jrheum.200721
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-566

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by the Journal of Rheumatology.

Auteurs

Arielle Mendel (A)

A. Mendel, MD, MSc, C.A. Pineau, MD, Division of Rheumatology, Lupus and Vasculitis Clinic, McGill University, Montréal, Québec; arielle.mendel@mcgill.ca.
ORCID: 0000-0001-9732-616X

Daniel Ennis (D)

D. Ennis, MD, C. Baldwin, MD, N. Dehghan, MD, N. Dhindsa, MD, Division of Rheumatology, University of British Columbia, Vancouver, British Columbia.

Ellen Go (E)

E. Go, MD, R.S. Yeung, MD, PhD, Division of Rheumatology, Hospital for Sick Children, University of Toronto, Toronto, Ontario.
ORCID: 0000-0001-8234-3047

Volodko Bakowsky (V)

V. Bakowsky, MD, Division of Rheumatology, QEII Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia.

Corisande Baldwin (C)

D. Ennis, MD, C. Baldwin, MD, N. Dehghan, MD, N. Dhindsa, MD, Division of Rheumatology, University of British Columbia, Vancouver, British Columbia.

Susanne M Benseler (SM)

S.M. Benseler, MD, PhD, M. Twilt, MD, PhD, Division of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta.

David A Cabral (DA)

D.A. Cabral, MBBS, Division of Pediatric Rheumatology, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia.
ORCID: 0000-0003-1840-9210

Simon Carette (S)

S. Carette, MD, MPhil, C. Pagnoux, MD, MSc, MPH, Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario.

Marie Clements-Baker (M)

M. Clements-Baker, MD, T.E. Towheed, MD, MS, Division of Rheumatology, Queen's University, Kingston, Ontario.

Alison H Clifford (AH)

A.H. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E. Yacyshyn, MD, Division of Rheumatology, University of Alberta, Edmonton, Alberta.

Jan Willem Cohen Tervaert (JW)

A.H. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E. Yacyshyn, MD, Division of Rheumatology, University of Alberta, Edmonton, Alberta.
ORCID: 0000-0001-7407-6364

Gerard Cox (G)

G. Cox, MB, Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario.

Natasha Dehghan (N)

D. Ennis, MD, C. Baldwin, MD, N. Dehghan, MD, N. Dhindsa, MD, Division of Rheumatology, University of British Columbia, Vancouver, British Columbia.

Christine Dipchand (C)

C. Dipchand, MD, MSc, Division of Nephrology, QEII Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia.

Navjot Dhindsa (N)

D. Ennis, MD, C. Baldwin, MD, N. Dehghan, MD, N. Dhindsa, MD, Division of Rheumatology, University of British Columbia, Vancouver, British Columbia.

Leilani Famorca (L)

L. Famorca, MD, S. Garner, MD, MSc, N. Khalidi, MD, Division of Rheumatology, McMaster University, Hamilton, Ontario.

Aurore Fifi-Mah (A)

A. Fifi-Mah, MD, Division of Rheumatology, University of Calgary, Calgary, Alberta.

Stephanie Garner (S)

L. Famorca, MD, S. Garner, MD, MSc, N. Khalidi, MD, Division of Rheumatology, McMaster University, Hamilton, Ontario.

Louis-Philippe Girard (LP)

L.P. Girard, MD, MSc, Division of Nephrology, University of Calgary, Calgary, Alberta.
ORCID: 0000-0002-9044-008X

Clode Lessard (C)

C. Lessard, MD, Centre de Recherche Musculo-Squelettique, Trois-Rivières, Québec.

Patrick Liang (P)

P. Liang, MD, Division of Rheumatology, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec.

Damien Noone (D)

D. Noone, MB, BCh, BAO, MSc, Division of Nephrology, Hospital for Sick Children, University of Toronto, Toronto, Ontario.

Jean-Paul Makhzoum (JP)

J.P. Makhzoum, MD, M. Rhéaume, MD, Division of Internal Medicine, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal, Québec.
ORCID: 0000-0003-4523-8525

Nataliya Milman (N)

N. Milman, MD, MSc, Division of Rheumatology, The Ottawa Hospital, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario.
ORCID: 0000-0002-7353-7007

Christian A Pineau (CA)

A. Mendel, MD, MSc, C.A. Pineau, MD, Division of Rheumatology, Lupus and Vasculitis Clinic, McGill University, Montréal, Québec.

Heather N Reich (HN)

H.N. Reich, MD, PhD, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario.
ORCID: 0000-0001-8951-5518

Maxime Rhéaume (M)

J.P. Makhzoum, MD, M. Rhéaume, MD, Division of Internal Medicine, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal, Québec.

David B Robinson (DB)

D.B. Robinson, MD, MSc, Section of Rheumatology, University of Manitoba, Winnipeg, Manitoba.

Dax G Rumsey (DG)

D.G. Rumsey, MD, MSc, Division of Pediatric Rheumatology, University of Alberta, Edmonton, Alberta.

Tanveer E Towheed (TE)

M. Clements-Baker, MD, T.E. Towheed, MD, MS, Division of Rheumatology, Queen's University, Kingston, Ontario.

Judith Trudeau (J)

J. Trudeau, MD, Division of Rheumatology, CISSS Chaudière-Appalaches, Université Laval, Québec City, Québec.
ORCID: 0000-0001-8976-0492

Marinka Twilt (M)

S.M. Benseler, MD, PhD, M. Twilt, MD, PhD, Division of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta.
ORCID: 0000-0003-1954-2822

Elaine Yacyshyn (E)

A.H. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E. Yacyshyn, MD, Division of Rheumatology, University of Alberta, Edmonton, Alberta.

Rae S M Yeung (RSM)

E. Go, MD, R.S. Yeung, MD, PhD, Division of Rheumatology, Hospital for Sick Children, University of Toronto, Toronto, Ontario.

Lillian B Barra (LB)

L.B. Barra, MD, Division of Rheumatology, Department of Medicine, Western University, London, Ontario, Canada.
ORCID: 0000-0001-8614-6972

Nader Khalidi (N)

L. Famorca, MD, S. Garner, MD, MSc, N. Khalidi, MD, Division of Rheumatology, McMaster University, Hamilton, Ontario.

Christian Pagnoux (C)

S. Carette, MD, MPhil, C. Pagnoux, MD, MSc, MPH, Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario.
ORCID: 0000-0001-6287-9549

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

Recherchemedicale.com › Maladies du système immunitaire › Maladies auto-immunes › Vascularites associées aux anticorps anti-cytoplasme des neutrophiles › CanVasc Consensus Recommendations for the...
Recherchemedicale.com › Facteurs biologiques › Marqueurs biologiques › Anticorps anti-cytoplasme des polynucléaires neutrophiles › CanVasc Consensus Recommendations for the...
Recherchemedicale.com › Régions géographiques › Amériques › Amérique du Nord › Canada › CanVasc Consensus Recommendations for the...
Recherchemedicale.com › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › CanVasc Consensus Recommendations for the...
Recherchemedicale.com › Cellules › Structures cellulaires › Espace intracellulaire › Cytoplasme › CanVasc Consensus Recommendations for the...
Recherchemedicale.com › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › CanVasc Consensus Recommendations for the...